Guillermo and Brett interview, Albert Gutierrez, President of MedPharm, who shares his journey from tech to cannabis. The conversation focuses on research, product quality, and consumer education—highlighting MedPharm’ innovative work. Albert emphasizes the importance of research, regulatory challenges, and consumer education, stressing the need for high-quality, standardized products. The episode concludes with a call for ongoing education and community engagement.
Listen and Learn
- Importance of cannabis research and its role in the industry.
- Challenges and successes in cannabis product development and research.
- Need for standardized products and certifications in the cannabis industry.
- Discussion on the complexities of cannabis consumption methods and their effects.
- Importance of consumer education regarding product safety and quality.
- Challenges faced by the cannabis industry, including regulation and market saturation.
- Future potential of cannabis research and its impact on medical applications.
Episode Resources
- Book a free consultation with Guillermo
- Email us to be a guest on the show
- Sign up for our newsletter
- Connect with Albert Gutierrez on LinkedIn
- Check out MedPharm
Looking to accelerate the growth of your Cannabis business? Learn more about our Virtual CFO services for Cannabis businesses.
Our firm provides this information for general educational guidance only and does not constitute the provision of legal advice, tax advice, accounting services, investment advice, or professional consulting of any kind. The information provided herein should not be used as a substitute for consultation with professional tax, accounting, legal, or other competent advisers. Before making any decision or taking any action, you should consult a professional adviser who has been provided with all pertinent facts relevant to your particular situation. Podcasts posted by Anders CPAs + Advisors are not intended to be used and cannot be used by any individual or business, for the purpose of avoiding accuracy-related penalties that may be imposed on the taxpayer. The information is provided "as is," with no assurance or guarantee of completeness, accuracy, or timeliness of the information, and without warranty of any kind, express or implied, including but not limited to warranties of performance, merchantability, and fitness for a particular purpose. Please note that some content may be generated using artificial intelligence and is intended for educational and informational purposes only. In no way does listening, reading, emailing or interacting on social media with our content establish a professional relationship.
All Insights
